Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  American Journal of Pathology

• Publication date

  1978-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 568888PMCID PMC2018385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of the migration patterns of normal and malignant cells in two assay systems.

  1978cited by this paper
• Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1.

  1977cited by this paper
• Interaction of chemotactic factors with human macrophages: induction of transmembrane potential changes

  1977cited by this paper
• Further studies on the C5-derived chemotactic factor for tumor cells.

  1976cited by this paper
• Characterization of two different factors chemotactic for cancer cells from tumor tissue

  1976cited by this paper
• A unique complement derived chemotactic factor for tumor cells.

  1975cited by this paper
• Isoelectric focusing in layers of granulated gels. II. Preparative isoelectric focusing.

  1975cited by this paper
• Two distinct chemotactic factor inactivators in human serum.

  1975cited by this paper
• Recognition in leucocyte chemotaxis. Studies with structurally modified proteins.

  1974cited by this paper
• LEUKOCYTE LOCOMOTION AND CHEMOTAXIS

  1973cited by this paper
• FORMATION OF C3a AND C5a ANAPHYLATOXINS IN WHOLE HUMAN SERUM AFTER INHIBITION OF THE ANAPHYLATOXIN INACTIVATOR

  1973cited by this paper
• Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

  1972cited by this paper
• Studies on the mechanisms of invasion in cancer. II. In vivo effects of a factor chemotactic for cancer cells

  1971cited by this paper
• Studies on the mechanisms of invasion in cancer. I. Isolation and purification of a factor chemotactic for cancer cells

  1970cited by this paper
• Chemotactic Factor associated with Invasion of Cancer Cells

  1970cited by this paper
• Bacterial factors chemotactic for polymorphonuclear leukocytes.

  1968cited by this paper
• Estimation of the molecular weights of proteins by Sephadex gel-filtration.

  1964cited by this paper
• INTERACTIONS BETWEEN RABBIT POLYMORPHONUCLEAR LEUCOCYTES AND STAPHYLOCOCCI

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The first fifty years in research.

  2009cites this paper
• Tumor invasion and host extracellular matrix

  2004cites this paper
• Themotaxis of metastatic tumor cells

  2004cites this paper
• Generation and characterization of a neutrophil-derived inhibitor of fibroblast chemotaxis

  2004cites this paper
• Cell Biology International Reports, Vol. 5, No. 5, May 1987 Chemotactic Factor-Induced Adherence of Tumor Cells

  2003cites this paper
• Pathology of Bone Metastatic Tumours

  2002cites this paper
• Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.

  2002cites this paper
• Bone Metastases

  2002cites this paper
• The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor‐induced osteolysis

  2001cites this paper
• Treatment with ibandronate preserves bone in experimental tumour-induced bone loss.

  2000cites this paper
• Cancer Cell Chemotaxis: Mechanisms and Influence on Site-Specific Tumor Metastasis

  1994cites this paper
• Expression of autocrine motility-like factor in rheumatoid synovial fluid.

  1994cites this paper
• Expression of autocrine motility factor receptor in serum‐ and protein‐independent fibrosarcoma cells: Implications for autonomy in tumor‐cell motility and metastasis

  1993cites this paper
• Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities.

  1993cites this paper
• Enfermedad metastásica de la columna vertebral: evaluación y resultados (cuarta parte)

  1993cites this paper
• PMN adhesion and extravasation as a paradigm for tumor cell dissemination

  1991cites this paper
• Change in organotropism of mouse lymphoma variants associated with selective chemotactic responsiveness to organ-derived chemoattractants

  1991cites this paper
• Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat Walker 256 carcinosarcoma cells.

  1990cites this paper
• The effects of retinoic acid and butyric acid on in vitro migration by murine B16a cells: a quantitative scanning electron microscopic study.

  1989cites this paper
• Organ-specific chemotactic factors present in lung extracellular matrix.

  1989cites this paper
• A new long-term in vitro invasion assay using fibrous connective tissue matrices maintaining architectural characteristics of connective tissue.

  1988cites this paper
• Biological activities of complement-derived peptides.

  1987cites this paper
• Laminin and Fibronectin Modulate the Metastatic Activity of Melanoma Cells

  1987cites this paper
• Effects of neutrophil-mediated pulmonary endothelial injury on the localization and metastasis of circulating Walker carcinosarcoma cells.

  1987cites this paper
• Locomotion of tumor cells as an element of invasion and metastasis.

  1987cites this paper
• Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines.

  1987cites this paper
• Mechanisms of cancer metastasis to bone.

  1986cites this paper
• Basement membrane and the invasive activity of metastatic tumor cells.

  1986cites this paper
• Enhanced migration of tumor cells in response to collagen degradation products and tumor cell collagenolytic activity.

  1986cites this paper
• Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.

  1986cites this paper
• Chemotaxis in Tumor Cells: Possible Mechanisms and their Implications for Therapy

  1986cites this paper
• Advances in Immunity and Cancer Therapy

  1986cites this paper
• Pulmonary inflammation generates chemotactic activity for tumor cells and promotes lung metastasis.

  1985cites this paper
• CHAPTER 17 – Autoimmune Cutaneous Diseases*

  1985cites this paper
• Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells.

  1985cites this paper
• Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy.

  1985cites this paper
• Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites.

  1985cites this paper
• Effect of microtubule inhibitors on invasion and on related activities of tumor cells.

  1984cites this paper
• Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis.

  1984cites this paper
• Biologically active complement (C5)-derived peptides and their relevance to disease.

  1984cites this paper
• Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells.

  1984cites this paper
• Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.

  1983cites this paper
• Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells.

  1983influential citation
• Modulation of tumor cell adherence by prostaglandins.

  1983cites this paper
• Bullous pemphigoid and pemphigus vulgaris.

  1983cites this paper
• Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.

  1983cites this paper
• Chemotaxis of tumor cells.

  1983cites this paper
• The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.

  1983cites this paper
• Chemotactic mechanisms and cancer metastasis.

  1982cites this paper
• Role of monocytes in bone resorption.

  1982cites this paper
• Chemotaxis of metastatic tumor cells.

  1982cites this paper
• Biochemical mechanisms involved in tumor cell penetration of the basement membrane

  1982cites this paper
• Phorbol myristate acetate-induced adherence of Walker 256 carcinosarcoma cells.

  1982cites this paper
• Tumor cell Chemotaxis

  1982cites this paper
• Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.

  1982cites this paper
• Digestion of the fifth component of complement by eosinophil lysosomal enzymes

  1981cites this paper
• Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide.

  1981cites this paper
• Isolation of three separate anaphylatoxins from complement-activated human serum

  1981cites this paper
• The chemotactic response of tumor cells. A model for cancer metastasis.

  1981cites this paper
• Collagen and collagen-derived fragments are chemotactic for tumor cells.

  1981cites this paper
• Chemotactic factor-induced adherence of tumor cells.

  1981cites this paper
• Complement Deficiencies of Laboratory Animals

  1981cites this paper
• Characteristics of the chemotactic factor-mediated cell swelling response of tumor cells.

  1981cites this paper
• Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.

  1981cites this paper
• Adhesive characteristics of tumor cell variants of high and low tumorigenic potential.

  1980cites this paper
• Size increase induced in Walker ascites cells by chemotactic factors.

  1980cites this paper
• In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

  1980cites this paper
• Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.

  1980cites this paper
• Partial characterization of a bone-derived chemotactic factor for tumor cells.

  1980cites this paper
• Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.

  1979cites this paper
• Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.

  1979cites this paper
• Generation of biologic activity from the purified alpha-chain of C5.

  1979cites this paper
• Chemotactic responses of tumor cells to products of resorbing bone.

  1979cites this paper